Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared a post on X:
“A pleasure to have Paolo Tarantino from Dana-Farber’s Breast Oncology Center come to Hong-Kong to share with us his experiences and insights on development of ADCs. Lots of efforts ongoing to fine tune this technology and identify best therapeutic position for these agents.”
More posts featuring Herbert Loong and Paolo Tarantino on OncoDaily.
